Skip to main content
Fig. 5 | BMC Biology

Fig. 5

From: Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma

Fig. 5

The distinct immune landscape and immunotherapy responses underlying TRLS. A The relative infiltration levels of 28 immune cell types. B Tumor immunogenicity evaluation between the high- and low-risk groups. C Correlation analysis of TRLS with cancer immune circulation (CIC) and immunotherapeutic signatures. D, E Correlations of TRLS with CD274 (D) and PD-L1 protein (E). F The distribution of TIDE scores between the two risk groups. G The SubMap analysis assessed the similarity of expression profile between the independent immunotherapy and the two risk groups. P values are shown as *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page

BMC Biology

ISSN: 1741-7007

Contact us